 Home > Active Ingredient News > Blood System > Hyperkalemia drug Veltassa shows benefits for patients with heart failure

Hyperkalemia drug Veltassa shows benefits for patients with heart failure

 Last Update: 2021-12-24
 Source: Internet
 Author: User

Tags

potassium peroxide

main source protein

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Hyperkalemia is a serious disease characterized by elevated potassium levels in the blood

In some cases, the main problem that causes hyperkalemia is the transfer of potassium ions to the outside of the cell

diabetes

Vifor Pharma reported on Tuesday that its hyperkalemia treatment Veltassa (patiromer) reached the primary end point of the Phase IIIb trial (DIAMOND study), which helps to control the serum potassium levels of patients with heart failure

FDA

This global, multicenter, double-blind, placebo-controlled DIAMOND study aims to evaluate the potential role of Veltassa (patiromer) in allowing patients at risk of hyperkalemia or hyperkalemia to continue to receive RAASi treatment

Vascular COVID-19 prevention

Original source:

https://firstwordpharma.

https://firstwordpharma.
com/story/5466375 https://firstwordpharma.
com/story/5466375

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Gadusol Powder Gadusol76663-30-4

CAS No.: 76663-30-4

Industrial Grade

$1-1.01/G FOB

Food Additive Iron fumarate for Nutritional Iron Supplements

CAS No.: 141-01-5

Pharmacy Grade

$24-26/G FOB

Aminobenzoic Acid CAS 56-91-7

CAS No.: 56-91-7

Pharmaceutical Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.